跳至主要内容
临床试验/NCT07682610
NCT07682610招募中不适用

Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System (Kentucky QUILS™ Implementation): HSR Intervention

Timothy Mullett17 个研究点 分布在 1 个国家目标入组 35,500 人开始时间: 2025年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
35,500
试验地点
17
主要终点
Change in Quality Improvement Lung Cancer Screening (QUILS) Index Assessment Score

研究概览

简要总结

This clinical trial studies statewide optimization of lung cancer screening (LCS) in Kentucky using the Quality Implementation of Lung Screening (QUILS™) System. Data from the Kentucky Cancer Registry shows that LCS implementation has contributed to a rapid decline in late-stage lung cancer diagnosis at twice the national average. Further, the declines are more than three times the national average decline in Kentucky's Central Appalachian region. Kentucky-based multilevel initiatives are needed to expand and accelerate this leading role and extend the LCS opportunity to more Kentuckians who are at increased risk of lung cancer. This trial may be able to accelerate optimal high-quality implementation of LCS utilizing the QUILS™ System and reduce the burden of lung cancer by assisting lung cancer screening programs located throughout Kentucky in implementing best practices in lung cancer screening by integrating the QUILS™ System domains and elements into their screening programs.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Member of a participating Lung Cancer Screening Program (LCSP) team or administrator
  • Willing to participate in the QUILS Index Assessment Survey process
  • Willing to participate in the QUILS Audit Feedback presentations
  • Willing to participate in formative evaluation interviews

排除标准

  • Unwilling to participate in the QUILS Index Assessment Survey process
  • Unwilling to participate in the QUILS Audit Feedback presentations
  • Unwilling to participate in formative evaluation interviews

结局指标

主要结局

Change in Quality Improvement Lung Cancer Screening (QUILS) Index Assessment Score

时间窗: Baseline and Month 9

The QUILS Index Assessment is a program-level measure of lung cancer screening implementation quality. Scores range from 0 to 95, with a higher score indicating higher quality implementation of lung cancer screening practices. The outcome measure is the change in total QUILS Index score from Baseline to 12 months.

次要结局

未报告次要终点

研究者

发起方
Timothy Mullett
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Timothy Mullett

Professor

University of Kentucky

研究点 (17)

Loading locations...

相似试验